You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 12, 2025

Drug Price Trends for QC ASPIRIN EC


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for QC ASPIRIN EC

Average Pharmacy Cost for QC ASPIRIN EC

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
QC ASPIRIN EC 325 MG TABLET 83324-0058-01 0.02166 EACH 2025-02-05
QC ASPIRIN EC 81 MG TABLET 83324-0089-05 0.01368 EACH 2025-01-29
QC ASPIRIN EC 81 MG TABLET 83324-0090-36 0.01368 EACH 2025-01-22
QC ASPIRIN EC 81 MG TABLET 83324-0090-36 0.01317 EACH 2024-12-18
QC ASPIRIN EC 81 MG TABLET 83324-0090-36 0.01244 EACH 2024-12-11
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Aspirin: A Comprehensive Overview

Introduction to Aspirin Market

Aspirin, one of the most widely used medications globally, is a staple in the pharmaceutical industry. It is utilized for treating a variety of medical conditions, including fever, pain, and aches. Here, we will delve into the current market analysis and price projections for aspirin, highlighting key trends, geographical dynamics, and future outlook.

Global Aspirin Market Size and Forecast

The global aspirin market is projected to experience steady growth over the coming years. As of 2024, the market size was valued at approximately USD 2.26 billion and is expected to reach USD 2.75 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 2.47% during the forecast period[1][4].

Geographical Market Dynamics

Asia Pacific

The Asia-Pacific region, particularly China and India, is expected to drive the highest growth in the aspirin market. These countries are leaders in the production of Active Pharmaceutical Ingredients (APIs) and cater to global demand. The large population base in these regions, coupled with the rapid expansion of pharmacies providing Over-The-Counter (OTC) medicines, contributes significantly to the market growth[1][4].

Europe

Europe is the second-largest market for aspirin, with Germany being a key player due to the presence of niche market leaders like Bayer AG. The region experiences a high demand for aspirin, especially for treating conditions such as migraines[1].

North America

North America, including the U.S., Canada, and Mexico, also sees a significant market share driven by the prevalence of headaches and migraines. The region's market is influenced by factors such as rising production costs and stable demand from end-user industries[1][3].

Rest of the World

Latin America and the Middle East & Africa regions also contribute to the global aspirin market, although to a lesser extent. These regions are expected to grow as healthcare expenditure and investments in the pharmaceutical industry increase[1].

Price Trends and Projections

Current Price Trends

In the third quarter of 2024, aspirin prices in various regions showed an upward trajectory. In Asia, prices increased due to robust demand and tightening supply conditions, particularly in China. European prices also rose due to strong market fundamentals and supply chain disruptions. In North America, the U.S. domestic market experienced steady price appreciation driven by rising production costs and supply chain bottlenecks[3].

Future Price Projections

Analysts predict that aspirin prices will continue to rise in the upcoming months due to sustained demand and persistent supply chain challenges. The market outlook remains positive, with potential for further price increases dependent on these factors[3].

Market Drivers and Restraints

Drivers

  • Increasing Prevalence of Contagious Diseases: The rising rate of flu and cold cases, especially in densely populated areas, drives the demand for aspirin[4].
  • Growing Pharmaceutical Industry: The robust pharmaceutical industry in regions like China and India supports market growth[4].
  • Healthcare Expenditure: Increasing healthcare expenditure and investments in regional pharma industries propel market growth[4].

Restraints

  • Associated Side Effects: The potential side effects of aspirin intake, such as gastrointestinal issues, can restrict market growth[4].
  • Supply Chain Disruptions: Logistical crises and supply chain disruptions can impact the availability and pricing of aspirin[3].

Competitive Landscape

The global aspirin market is led by several key players, including:

  • Bayer AG: Known for its low-dose enteric-coated aspirin tablets, Bayer is a significant player in the European market[1][4].
  • Allegiant Health: Along with other companies like Globalimporter Inc., Cardinal Health, and Par Pharmaceutical, these entities play crucial roles in the global aspirin market[1][4].

Novel Formulations and Innovations

Recent developments in the use of aspirin, such as the formulation of hydrogels where aspirin is used as an additive, are expected to boost market growth. These novel formulations can expand the applications of aspirin beyond traditional uses[1].

Quality Control and Regulatory Aspects

Quality control assessments of locally manufactured aspirin tablets are crucial to ensure compliance with global standards. Studies have compared the quality of locally produced aspirin tablets with globally produced generics, highlighting the importance of regulatory oversight[2].

Key Takeaways

  • The global aspirin market is projected to grow from USD 2.26 billion in 2024 to USD 2.75 billion by 2031.
  • Asia-Pacific, particularly China and India, will drive the highest growth due to a robust pharmaceutical industry and large population base.
  • Europe and North America will also see significant market shares driven by demand for treating conditions like migraines and headaches.
  • Aspirin prices are expected to rise due to sustained demand and supply chain challenges.
  • Key market drivers include the increasing prevalence of contagious diseases and growing healthcare expenditure, while side effects and supply chain disruptions act as restraints.

FAQs

What is the projected market size of the global aspirin market by 2031?

The global aspirin market is projected to reach USD 2.75 billion by 2031[1].

Which region is expected to drive the highest growth in the aspirin market?

The Asia-Pacific region, particularly China and India, is expected to drive the highest growth in the aspirin market[1][4].

What are the key drivers of the aspirin market?

Key drivers include the increasing prevalence of contagious diseases, growing pharmaceutical industry, and increasing healthcare expenditure[4].

Which companies are leading the global aspirin market?

Key players include Bayer AG, Allegiant Health, Globalimporter Inc., Cardinal Health, and Par Pharmaceutical[1][4].

What are the potential restraints to the aspirin market growth?

Potential restraints include associated side effects of aspirin intake and supply chain disruptions[3][4].

Sources

  1. Verified Market Research: In-Depth Industry Outlook: Aspirin Market Size & Forecast.
  2. ResearchGate: Quality control assessment of locally manufactured Aspirin tablets in comparison to globally produced generics.
  3. Procurement Resource: Aspirin Price Trend, Index, News, Chart, Database.
  4. Zion Market Research: Aspirin Market Size, Share, Value and Forecast 2030.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.